Newsroom

LONDON--(BUSINESS WIRE)--  Re: PARAGON MORTGAGES NO 12 PLC EUR 106,000,000.00 MATURING: 15-Nov-2038 ISIN: XS0261650674 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 15-May-2026 TO 17-Aug-2026 HAS BEEN FIXED AT 3.20 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 17-Aug-2026 WILL AMOUNT TO: EUR 147.83 PER EUR 17,675.62 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  12-May-2026 Issue: Newday Funding Master Issuer Plc Series 2024-3 Class F 144A XS2909753365 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-April-2026 Date To: 15-May-2026 Record Date: 14-May-2026 Value Date: 15-May-2026 Benchmark Rate: 3.73528102% Margin: 4.75% Total Rate: 8.48528102% Number of Days: 30 Day Count: Actual / 365L Interest Frequency: Monthly Total Amount Due:...

LONDON--(BUSINESS WIRE)--  Re: Corporacion Andina De Fomento UYU 228,933,351.00 MATURING: 16-May-2039 ISIN: XS2720184642 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 14-Nov-2025 TO 14-May-2026 HAS BEEN FIXED AT 3.76 PCT DAY BASIS: 30/360 INTEREST PAYABLE VALUE 14-May-2026 WILL AMOUNT TO: UYU 108,355.72 PER UYU 204,664,126.46 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  12-May-2026 Issue: Newday Funding Master Issuer Plc Series 2024-1 Class C 144A XS2768182953 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-April-2026 Date To: 15-May-2026 Record Date: 14-May-2026 Value Date: 15-May-2026 Benchmark Rate: 3.73528% Margin: 2.4% Total Rate: 6.13528% Number of Days: 30 Day Count: Actual / 365L Interest Frequency: Monthly Total Amount Due: GBP 0.0...

LONDON--(BUSINESS WIRE)--  12-May-2026 Issue: Newday Funding Master Issuer Plc 2025-1 Class B REGS XS3031495115 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-April-2026 Date To: 15-May-2026 Record Date: 14-May-2026 Value Date: 15-May-2026 Benchmark Rate: 3.73528% Margin: 1.15% Total Rate: 4.88528% Number of Days: 30 Day Count: Actual / 365L Interest Frequency: Monthly Total Amount Due: GBP 115,239.0...

NEW YORK & PARIS--(BUSINESS WIRE)--Owkin, het agentic AI-bedrijf dat pionierswerk verricht in Biological Artificial Superintelligence om de ontdekking en ontwikkeling van geneesmiddelen revolutionair te veranderen, maakte vandaag een overeenkomst met AstraZeneca bekend om biofarma-agents te bouwen in het kader van een driejarige licentieverlening van K Pro – de AI Scientist van Uwkin voor het nemen van beslissingen in biofarma. Deze bekendmaking is officieel geldend in de originele brontaal. Ve...

NEW YORK & PARIGI--(BUSINESS WIRE)--Owkin, l'azienda IA agenziale all'avanguardia nella superintelligence artificiale biologica per rivoluzionare la ricerca e lo sviluppo di farmaci, ha annunciato oggi la sottoscrizione di un accordo con AstraZeneca per sviluppare agenti biofarmaceutici come parte dell'accordo di licenza triennale dello scienziato IA di Owkin, K Pro, per il processo decisionale in ambito biofarmaceutico. Il testo originale del presente annuncio, redatto nella lingua di partenza...

LONDON--(BUSINESS WIRE)--  12-May-2026 Issue: Newday Funding Master Issuer Plc Series 2024-3 Class F RegS XS2909753282 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-April-2026 Date To: 15-May-2026 Record Date: 14-May-2026 Value Date: 15-May-2026 Benchmark Rate: 3.73528% Margin: 4.75% Total Rate: 8.48528% Number of Days: 30 Day Count: Actual / 365L Interest Frequency: Monthly Total Amount Due: GBP 31...

NUEVA YORK & PARÍS--(BUSINESS WIRE)--Owkin —la compañía de IA agéntica pionera en "superinteligencia artificial biológica" que revoluciona el descubrimiento y desarrollo de fármacos— anunció hoy un acuerdo con AstraZeneca para desarrollar agentes biofarmacéuticos como parte de la licencia por tres años de K Pro, el sistema de IA científica de Owkin para la toma de decisiones vinculadas con biofármacos. El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traduc...

LONDON--(BUSINESS WIRE)--  Re: Atlas Funding 2025-2 plc GBP 4,500,000.00 MATURING: 20-Jul-2067 ISIN: XS3212017688 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Apr-2026 TO 20-May-2026 HAS BEEN FIXED AT 8.24 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 20-May-2026 WILL AMOUNT TO: GBP 30,459.33 PER GBP 4,500,000.00 DENOMINATION  ...